NCT05679557
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark
Clinical trial condition
Bladder Cancer
Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.
771 public trials
174 recruiting studies
Bladder Cancer trial results
NCT07424560
- Conditions
- Adjuvant Therapy for Bladder Cancer, Bladder Cancer, Bladder Cancer Recurrence, +12 more
- Locations
-
- The Second Hospital of Lanzhou University Lanzhou, Gansu, China
Recruiting
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
NCT07410676
- Conditions
- Adnexal Diseases, Astrocytoma, Bladder Cancer, +88 more
- Locations
-
- District One Hospital Beijing, Beijing Municipality, China
NCT07030257
- Conditions
- Bladder Cancer, Bronchial Neoplasms, Carcinoma, +47 more
- Locations
-
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Florida Cancer Specialists-Lake Nona Orlando, Florida, United States
- START Midwest Grand Rapids, Michigan, United States
- Washington University St Louis, Missouri, United States
Recruiting
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
NCT06470282
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT07403630
- Conditions
- Acute Leukemia, Adenoma, Adnexal Diseases, +73 more
- Locations
-
- AO Riuniti Villa Sofia-Cervello di Palermo Palermo, Italy
- University of Perugia Perugia, Italy
NCT07234968
- Conditions
- Bladder Cancer, Bladder Neoplasm, Bladder Transitional Cell Carcinoma, +20 more
- Locations
-
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
- Jefferson Einstein Philadelphia Hospital Philadelphia, Pennsylvania, United States
NCT06138561
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
NCT06778863
- Conditions
- Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +51 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- The University of Arizona Cancer Center Tucson, Arizona, United States
- USC - Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT04368702
- Conditions
- Bladder Cancer, Breast Carcinoma In Situ, Breast Diseases, +44 more
- Locations
-
- Brigham & Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States